Luzuriaga, KatherineGay, HannahZiemniak, CarrieSanborn, Keri B.Somasundaran, MohanRainwater-Lovett, KaitlinMellors, John W.Rosenbloom, DanielPersaud, Deborah2022-08-232022-08-232015-02-192019-04-24<p>N Engl J Med. 2015 Feb 19;372(8):786-8. doi: 10.1056/NEJMc1413931. <a href="https://doi.org/10.1056/NEJMc1413931">Link to article on publisher's site</a></p>0028-4793 (Linking)10.1056/NEJMc141393125693029https://hdl.handle.net/20.500.14038/50355We previously reported the remission of human immunodeficiency virus type 1 (HIV-1) in a perinatally infected child — the “Mississippi Child.” After receiving antiretroviral therapy (ART) between 30 hours and 18 months of age, this child had persistently undetectable plasma HIV-1 viremia for 12 months in the absence of HIV-1–specific immune responses. At the time of the initial case report, it was uncertain whether HIV-1 reservoirs were established that could lead to rebound viremia.en-USPublisher PDF posted after 6 months as allowed by publisher's Author Permissions policy at: https://www.nejm.org/author-center/permissionsUMCCTS fundingInfectious DiseaseMaternal and Child HealthTherapeuticsTranslational Medical ResearchVirus DiseasesVirusesViremic relapse after HIV-1 remission in a perinatally infected childJournal Articlehttps://escholarship.umassmed.edu/cgi/viewcontent.cgi?article=1192&amp;context=umccts_pubs&amp;unstamped=1https://escholarship.umassmed.edu/umccts_pubs/18314344363umccts_pubs/183